Imfinzi

197,00 

Therapeutic PD-L1-antibody from the original commercial drug Imfinzi targeting the PD-L1-antigen, also referred to as Durvalumab antibody.

Product Concentration [mg/mL] Volume per Vial [µL] Quantity per vial [mg] Batch Number Original therapeutic expiry date Availability Certificate of Analysis (CoA)* PriceQuantityTotal
50804AACY10/2021ready to shipno 197,00 
-
+
197,00 
spinner

Category: SKU: N/A

Description

Additional information

Therapeutic molecule

Durvalumab

Antigen

PD-L1

Product Concentration [mg/mL]

50

Volume per Vial [µL]

80

Quantity per vial [mg]

4

Batch Number

AACY

Original therapeutic expiry date

10/2021

Availability

3 wks, ready to ship

Certificate of Analysis (CoA)*

no

You may also like…